96 related articles for article (PubMed ID: 28017687)
1. Further psychometric validation of the GAH scale: Responsiveness and effect size.
Cruz-Jentoft AJ; González B; de la Rubia J; Hernández Rivas JÁ; Soler JA; Fernández Lago C; Arnao M; Gironella M; Pérez Persona E; Zudaire MT; Olivier C; Altés A; García Guiñón A; Nomdedeu B; Arnan M; Ramírez Payer Á; Sánchez-Godoy P; Pajuelo N; Vilanova D; Monjil DF; Bonanad S;
J Geriatr Oncol; 2017 May; 8(3):211-215. PubMed ID: 28017687
[TBL] [Abstract][Full Text] [Related]
2. Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.
Bonanad S; De la Rubia J; Gironella M; Pérez Persona E; González B; Fernández Lago C; Arnan M; Zudaire M; Hernández Rivas JA; Soler A; Marrero C; Olivier C; Altés A; Valcárcel D; Hernández MT; Oiartzabal I; Fernández Ordoño R; Arnao M; Esquerra A; Sarrá J; González-Barca E; González J; Calvo X; Nomdedeu M; García Guiñón A; Ramírez Payer A; Casado A; López S; Durán M; Marcos M; Cruz-Jentoft AJ;
J Geriatr Oncol; 2015 Sep; 6(5):353-61. PubMed ID: 26139300
[TBL] [Abstract][Full Text] [Related]
3. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
de la Rubia J; González B; Cruz-Jentoft AJ; Iglesias L; Jarque I; Persona EP; Lluch R; Marrero C; Zudaire M; Gironella M; Hernández-Rivas JÁ; Arnan M; Olivier C; Encinas C; Soler JA; Payer ÁR; Casado A; Fernández P; Vilanova D; Bonanad S
J Geriatr Oncol; 2023 Jan; 14(1):101401. PubMed ID: 36404260
[TBL] [Abstract][Full Text] [Related]
4. Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer.
Ghosn M; Ibrahim T; El Rassy E; Nassani N; Ghanem S; Assi T
J Geriatr Oncol; 2017 Mar; 8(2):128-132. PubMed ID: 27964884
[TBL] [Abstract][Full Text] [Related]
5. Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies.
Ramos F; González-Carmona P; Porras-Guerra MI; Jiménez-Mola S; Martínez-Peláez AM; Blanco-Cabielles A; Conde S; Ahmadi A; Castellanos M; Cerdá S; de Las Heras N; Menéndez E; Escalante F; Fernández-Ferrero S; Lado T; Martínez-Robles V; Rondón F; Padilla I; Vidal MJ; Villalobos ML; Yacoubi S; Idoate-Gil FJ; Rodríguez-García JA
J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32867114
[TBL] [Abstract][Full Text] [Related]
6. Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
Ümit EG; Kuloğlu F; Demir AM
Turk J Haematol; 2017 Mar; 34(1):89-92. PubMed ID: 27531123
[TBL] [Abstract][Full Text] [Related]
7. Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Garric M; Sourdet S; Cabarrou B; Steinmeyer Z; Gauthier M; Ysebaert L; Beyne-Rauzy O; Gerard S; Lozano S; Brechemier D; Filleron T; Mourey L; Balardy L
Eur J Haematol; 2021 May; 106(5):616-626. PubMed ID: 33340150
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
[TBL] [Abstract][Full Text] [Related]
9. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools.
de Kock I; Mirhosseini M; Lau F; Thai V; Downing M; Quan H; Lesperance M; Yang J
J Palliat Care; 2013; 29(3):163-9. PubMed ID: 24380215
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three established measures of fear of falling in community-dwelling older adults: psychometric testing.
Huang TT; Wang WS
Int J Nurs Stud; 2009 Oct; 46(10):1313-9. PubMed ID: 19394017
[TBL] [Abstract][Full Text] [Related]
11. Developing a cancer-specific geriatric assessment: a feasibility study.
Hurria A; Gupta S; Zauderer M; Zuckerman EL; Cohen HJ; Muss H; Rodin M; Panageas KS; Holland JC; Saltz L; Kris MG; Noy A; Gomez J; Jakubowski A; Hudis C; Kornblith AB
Cancer; 2005 Nov; 104(9):1998-2005. PubMed ID: 16206252
[TBL] [Abstract][Full Text] [Related]
12. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity and functional status are independent in older cancer patients.
Extermann M; Overcash J; Lyman GH; Parr J; Balducci L
J Clin Oncol; 1998 Apr; 16(4):1582-7. PubMed ID: 9552069
[TBL] [Abstract][Full Text] [Related]
14. Geriatric assessment-identified deficits in older cancer patients with normal performance status.
Jolly TA; Deal AM; Nyrop KA; Williams GR; Pergolotti M; Wood WA; Alston SM; Gordon BB; Dixon SA; Moore SG; Taylor WC; Messino M; Muss HB
Oncologist; 2015 Apr; 20(4):379-85. PubMed ID: 25765876
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
16. Validation of the G8 screening tool in older patients with aggressive haematological malignancies.
Velghe A; Petrovic M; De Buyser S; Demuynck R; Noens L
Eur J Oncol Nurs; 2014 Dec; 18(6):645-8. PubMed ID: 24954768
[TBL] [Abstract][Full Text] [Related]
17. A model for the functional assessment of elderly with myeloid neoplasms.
Carbonell AL; Salhab RM; Giampaoli V; Cendoroglo MS; Chauffaille Mde L
Rev Bras Hematol Hemoter; 2015; 37(2):109-14. PubMed ID: 25818821
[TBL] [Abstract][Full Text] [Related]
18. Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients.
Ornetti P; Parratte S; Gossec L; Tavernier C; Argenson JN; Roos EM; Guillemin F; Maillefert JF
Osteoarthritis Cartilage; 2010 Apr; 18(4):522-9. PubMed ID: 20060086
[TBL] [Abstract][Full Text] [Related]
19. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
20. [Development and validation of the Informant Assessment of Geriatric Delirium Scale (I-AGeD). Recognition of delirium in geriatric patients].
Rhodius-Meester HF; van Campen JP; Fung W; Meagher DJ; van Munster BC; de Jonghe JF
Tijdschr Gerontol Geriatr; 2013 Oct; 44(5):206-14. PubMed ID: 23943558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
